Biocept Inc (BIOCQ)

[Johnny_C]

CEO Michael Nall is a Covid scammer my friend. Not only has he and Biocept CFO Timothy Kennedy been caught red handed committing intentional fraud in SEC filings, they concealed material news from investors. Get ready for another Nall financing.

Nall keeps doubling down on his lies, as he stated that the company announced a supply agreement with Aegea. Well, I do not see a biocept press release or an 8K to that effect. Furthermore, Nall stated that Biocept and Aegea co own Switch Blocker patents decieving investors that Biocept coowns those patents outside of a few oncology indications. This guy is a real piece of work..

Covid testing is going to fall of the cliff, and nearly 95% of the revenue was Covid testing...

In regards to our collaboration with the Aegea Biotechnologies, earlier this month, after successfully developing a next-generation COVID-19 assay, we announced a supply agreement under which Aegea is providing us with the kits for validation and commercialization in our lab. This next-generation COVID-19 assay was developed using the patented Switch-Blocker technology that is jointly owned by Biocept and Aegea, which is the same technology that is the basis for many of our ultrasensitive oncology assays. Our current COVID-19 RT-PCR testing provides qualitative results only, meaning that sample is either positive or negative. The new codeveloped assay has the advantage of distinguishing various strains of the virus while providing quantitative viral load results. Healthcare providers can use this quantitative assay to monitor viral load over time in order to determine when a patient, a resident, student or employee can safely return to the general population. This new assay can also be modified to detect new variants of the SARS-CoV-2 virus as they emerge.